Concepedia
Statistics
Publications
5
Citations
688
H-Index
Active since
2020
Affiliations
Medical College of Wisconsin(Current)
Case Western Reserve University
University College London Hospitals NHS Foundation Trust
University College London
Manchester Academic Health Science Centre
Yajuan Qin is an author at Medical College of Wisconsin specializing in oncology, immunotherapy, and cancer immunotherapy.
Publications per year
2020–2021
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio et al. · The Lancet Oncology · 2021 · 417 citations
Medicine, Oncology, Pharmacotherapy +10
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma
Mehdi Hamadani, John Radford, Carmelo Carlo‐Stella et al. · Blood · 2020 · 169 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
Nitin Jain, Wendy Stock, Amer M. Zeidan et al. · Blood Advances · 2020 · 56 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization
Jaspreet Banga, Dinesh Srinivasan, Chia-Chi Sun et al. · Science Advances · 2020 · 29 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +11
Efficacy and Safety of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio et al. · Blood · 2020 · 17 citations
Medicine, Oncology, Pharmacotherapy +11
1–5 of 5